Summary & Overview

CPT 4040F: Pneumococcal Vaccine Immune Response

CPT code 4040F indicates that a pneumococcal vaccine has elicited an immune response or that the patient has received the vaccine. This code is used for documentation when the provider administers the vaccine to eligible populations — children under five years, adults 65 years and older, and individuals aged 6–64 with specified medical conditions — or when vaccination has been received previously. Nationally, accurate use of this code supports immunization tracking, preventive care quality measurement, and population-level monitoring of pneumococcal vaccine coverage.

Key payers included in coverage considerations are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for pneumococcal immunization, the common service settings where this code is reported, and guidance on what information this code documents on the claim. The publication also summarizes benchmark and policy implications for immunization documentation and quality reporting where relevant.

Data not available in the input for modifiers, associated taxonomies, ICD-10 diagnoses, related codes, and detailed service-line billing guidance.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare4040FCPTpneumococcal vaccineimmunizationpreventive carevaccine documentationambulatory carequality measurement

Billing Code Overview

CPT code 4040F documents that a pneumococcal vaccine has triggered an immune response or that the patient has received the vaccine. The code applies when the provider administers the vaccine or when the patient has a documented prior receipt of the vaccine.

Service type: Immunization / Vaccine administration and documentation

Typical site of service: Outpatient clinic, primary care office, public health clinic, or other ambulatory settings where immunizations are provided

Clinical & Coding Specifications

Clinical Context

A 68-year-old patient presents to a primary care clinic for routine preventive care. The clinician reviews the immunization history and documents no prior pneumococcal vaccination in the electronic medical record. After confirming no contraindications (e.g., severe allergic reaction to a prior dose or vaccine components), the nurse administers the pneumococcal vaccine during the visit, documents lot number, route, site, and consent, and updates the immunization registry. The clinical workflow includes pre-vaccination screening, counseling on common side effects, vaccine administration, observation for a short interval for adverse reactions, and documentation for billing. The service is typically provided in outpatient primary care clinics, community health centers, and long-term care facilities for adults aged 65 and older or younger patients with qualifying conditions such as chronic lung disease (e.g., asthma).

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure or other service	Use when a medically necessary E/M visit is performed and documented in addition to vaccine administration on the same date.
`59`

Taxonomy Code	Specialty	Notes
`207Q00000X`	Family Medicine	Primary providers who commonly administer adult and pediatric vaccines in outpatient settings.
`207R00000X`	Internal Medicine	Commonly administers pneumococcal vaccines to adults, especially those 65 and older and with chronic conditions.
`208000000X`	Pediatrics	Administers pneumococcal vaccines to children under five and documents routine childhood immunizations.
`261QU0200X`	Nurse Practitioner	Advanced practice clinicians who provide and document vaccine administration in clinic and community settings.
`363L00000X`	Public Health	Providers in public health clinics and immunization programs that deliver vaccines in community settings.

ICD-10 Code	Description	Clinical Relevance
`J45.909`	Unspecified asthma, uncomplicated	Asthma is a chronic lung condition that increases risk for pneumococcal disease; patients age 6–64 with asthma are recommended to receive pneumococcal vaccination per indications.
`J44.9`	Chronic obstructive pulmonary disease, unspecified	Chronic pulmonary disease increases risk of pneumococcal infection and is an indication for vaccination in adults under 65 with qualifying conditions.
`Z23`	Encounter for immunization	Administrative diagnosis code used to indicate the visit was for vaccine administration and for immunization registry and billing purposes.
`E10.9`	Type 1 diabetes mellitus without complications	Diabetes is a medical condition that can increase risk for invasive pneumococcal disease and is a common indication for vaccination in younger adults.
`D66`	Hereditary factor VIII deficiency	Certain immunocompromising or bleeding disorders can affect vaccine choice or administration planning and are relevant to pre-vaccination assessment.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`90460`	Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered	Use when counseling and vaccine administration for pediatric patients is separately reported; pairs with vaccine product codes for the administered immunogen.
`90461`	Immunization administration through 18 years of age; each additional vaccine/toxoid (list separately in addition to code for primary procedure)	Use when multiple pediatric vaccines are administered during the same encounter.
`90471`	Immunization administration (intramuscular, subcutaneous, or intradermal); one vaccine (single or first)	Report for adult immunizations when a single vaccine is administered and counseling/documentation supports the administration service.
`90472`	Immunization administration (intramuscular, subcutaneous, or intradermal); each additional vaccine/toxoid (single or first)	Report when additional vaccine(s) are administered during the same visit for adults.
`90670`	Pneumococcal conjugate vaccine, 13-valent, for intramuscular use	Represents the vaccine product code that may be reported in addition to administration codes when this specific pneumococcal vaccine is used.
`90732`	Pneumococcal polysaccharide vaccine, 23-valent, adult or pediatric	Represents an alternative pneumococcal vaccine product code reported with the administration; selection depends on age and clinical indications.

OpenPayer